SCN2A and epilepsy: To further investigate the model’s predictions within genes, we examined the 22 variants included in our test set from sodium voltage-gated channel alpha subunit 2 (SCN2A)—an important transmembrane protein implicated in seizure disorders [73] and autism spectrum disorders [74].